HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.77
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 168.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.05x
- Price / sales
- 95.76x
- Price / cash flow
- 23.69x
Enterprise value
- Enterprise value
- $5.8M
- EV / sales
- 44.83x
- EV / EBITDA
- -0.50x
- EV / EBIT
- -1.38x
- Market cap
- $12.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026